Literature DB >> 17657859

Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.

Xing-guo Lu1, Xian-guo Wu, Xiao-hua Xu, Xu-bo Gong, Xuan Zhou, Gen-bo Xu, Lei Zhu, Xiao-ying Zhao.   

Abstract

OBJECTIVE: The purpose of this work was to investigate the distribution pattern of fibrinolytic factors and their inhibitors in rabbit tissues.
METHODS: The components of the fibrinolytic system in extracts from a variety of rabbit tissues, including tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), plasminogen (Plg), plasmin (Pl) and alpha(2) plasmin inhibitor (alpha(2)PI), were determined by colorimetric assay.
RESULTS: The tissue extracts in renal, small intestine, lung, brain and spleen demonstrated strong fibrinolytic function, in which high activity of tPA, Plg and Pl was manifested; whereas in skeletal muscle, tongue and stomach, higher activity of PAI-1 and alpha(2)PI showed obviously. Also excellent linear correlations were found between levels of tPA and PAI-1, Pl and alpha(2)PI, Plg and Pl. In related tissues, renal cortex and renal marrow showed distinctly higher activity of tPA and lower activity of PAI-1, with the levels of Plg and Pl in renal cortex being higher than those in renal marrow, where the alpha(2)PI level was higher than that in renal cortex. Similarly, the levels of tPA, Plg and Pl in small intestine were higher than those in large intestine, but with respect to PAI-1 and alpha(2)PI, the matter was reverse. In addition, the fibrinolytic activity in muscle tissue was lower, however, the levels of tPA, Plg, and Pl in cardiac muscle were obviously higher than those in skeletal muscles, and the levels of PAI-1 and alpha(2)PI were significantly lower than those in skeletal muscle.
CONCLUSION: Our data demonstrate that a remarkable difference of the fibrinolytic patterns exists in rabbit tissues, which has probable profound significance in understanding the relationship between the function of haemostasis or thrombosis and the physiologic function in tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657859      PMCID: PMC1934952          DOI: 10.1631/jzus.2007.B0570

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  12 in total

1.  Reduction of gastric haemorrhage by fibrinolysis inhibition - an experimental study in rats.

Authors:  B Stenberg; L Karlsson; M Alpsten; B Risberg
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

2.  Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.

Authors:  L Gesualdo; E Ranieri; R Monno; M R Rossiello; M Colucci; N Semeraro; G Grandaliano; F P Schena; M Ursi; G Cerullo
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

3.  The pharmacokinetics of plasminogen activator inhibitor-1 in the rabbit.

Authors:  E J Mayer; T Fujita; S J Gardell; R J Shebuski; C F Reilly
Journal:  Blood       Date:  1990-10-15       Impact factor: 22.113

4.  Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.

Authors:  T Umeda; Y Eguchi; K Okino; M Kodama; T Hattori
Journal:  J Pathol       Date:  1997-12       Impact factor: 7.996

5.  [Plasminogen activator inhibitor type 1 (PAI-1) in blood and tissue extracts of patients with non-small cell lung cancer].

Authors:  Ewa Zekanowska; Krzysztof Cieśliński; Danuta Rość
Journal:  Pneumonol Alergol Pol       Date:  2004

6.  Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.

Authors:  B Casslén; T Bossmar; I Lecander; B Astedt
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

7.  Secretion of plasminogen activator inhibitor type 1 by cultured ovarian cells obtained from gonadotropin-treated immature rats.

Authors:  Y X Liu; Q Feng; X R Peng; N Tor
Journal:  Sci China B       Date:  1994-08

8.  Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA.

Authors:  Manfred Schmitt; Alexandra S Sturmheit; Anita Welk; Christel Schnelldorfer; Nadia Harbeck
Journal:  Methods Mol Med       Date:  2006

9.  Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis.

Authors:  K Sumiyoshi; S Baba; S Sakaguchi; T Urano; Y Takada; A Takada
Journal:  Thromb Res       Date:  1991-07-01       Impact factor: 3.944

10.  Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin.

Authors:  T Padró; P H Quax; C M van den Hoogen; P Roholl; J H Verheijen; J J Emeis
Journal:  Arterioscler Thromb       Date:  1994-09
View more
  1 in total

1.  ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.

Authors:  Erica Rurali; Federica Banterla; Roberta Donadelli; Elena Bresin; Miriam Galbusera; Sara Gastoldi; Flora Peyvandi; Mary Underwood; Giuseppe Remuzzi; Marina Noris
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-04       Impact factor: 8.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.